CTLA4 and neoplasm: This approach increases the number of immunosuppressive cells (such as tumor-associated macrophages, regulatory T-cells), reduces the count of immunoreactive cells (such as follicular helper T-cells), and upregulates the expression of immunosuppressive molecules (such as CTLA-4 and PD-1) within the TME.